{
    "Regions": {
        "1": "Africa",
        "2": "Americas",
        "3": "South-East Asia",
        "4": "Europe",
        "5": "Eastern Mediterranean",
        "6": "Western Pacific",
        "7": "Unspecified",
        "8": "Not known"
    },
    "Subregions": {
        "1": "China",
        "2": "Established Market Economies",
        "3": "Formerly Socialist Economies of Europe",
        "4": "India",
        "5": "Latin America and the Caribbean",
        "6": "Middle East Crescent",
        "7": "Other Asia and Islands",
        "8": "Sub-Saharan Africa",
        "9": "Global",
        "10": "Eastern Asia",
        "11": "Southern Asia",
        "12": "Low- and middle- income countries of the African Region",
        "13": "Low- and middle- income countries of the Americas",
        "14": "Low- and middle- income countries of the Eastern Mediterranean Region",
        "15": "Low- and middle- income countries of the European Region",
        "16": "Low- and middle- income countries of the South-east Asia Region",
        "17": "World",
        "18": "Low- and middle- income countries of the Western Pacific Region",
        "19": "High-income countries",
        "20": "Asia Pacific, High-income",
        "21": "Asia, Central",
        "22": "Asia, East",
        "23": "Asia, South",
        "24": "Asia, Southeast",
        "25": "Australasia",
        "26": "Caribbean",
        "27": "Europe, Central",
        "28": "Europe, Eastern",
        "29": "Europe, Western",
        "30": "Latin America, Andean",
        "31": "Latin America, Central",
        "32": "Latin America, Southern",
        "33": "Latin America, Tropical",
        "34": "North Africa/Middle East",
        "35": "North America, High-income",
        "36": "Oceania",
        "37": "Sub-Saharan Africa, Central",
        "38": "Sub-Saharan Africa, East",
        "39": "Sub-Saharan Africa, Southern",
        "40": "Sub-Saharan Africa, West",
        "41": "Unspecified",
        "42": "Not known"
    },
    "StudySubject": {
        "1": "Humans",
        "2": "Animals",
        "3": "Invertebrates",
        "4": "Bacteria",
        "5": "Viruses",
        "6": "Organism Forms, Other",
        "7": "Unspecified",
        "8": "Not applicable",
        "9": "Not known"
    },
    "Ethnicity": {
        "1": "Asian",
        "2": "Black",
        "3": "White",
        "4": "Mixed",
        "5": "Other",
        "6": "Unspecified",
        "7": "Not known"
    },
    "AgeGroups": {
        "1": "Adolescent",
        "2": "Adult",
        "3": "Aged",
        "4": "Frail Elderly",
        "5": "Child",
        "6": "Infant",
        "7": "Newborn",
        "8": "Other",
        "9": "Unspecified",
        "10": "Not applicable",
        "11": "Not known"
    },
    "Rurality": {
        "1": "Rural Population",
        "2": "Suburban Population",
        "3": "Urban Population",
        "4": "Unspecified",
        "5": "Not applicable",
        "6": "Not known"
    },
    "VulnerablePopulations": {
        "1": "Disabled persons",
        "2": "Drug users",
        "3": "Refugees",
        "4": "Indigenous People",
        "5": "Sexual and gender minorities ",
        "6": "Prisoners",
        "7": "Sex workers",
        "8": "Smokers",
        "9": "Women",
        "10": "Pregnant women",
        "11": "Minority communities unspecified",
        "12": "Vulnerable populations unspecified",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "OccupationalGroups": {
        "1": "Farmers",
        "2": "Emergency Responders",
        "3": "Military Personnel",
        "4": "Social Workers",
        "5": "Caregivers",
        "6": "Health Personnel",
        "7": "Hospital personnel ",
        "8": "Nurses and Nursing Staff",
        "9": "Physicians",
        "10": "Dentists and dental staff ",
        "11": "Veterinarians",
        "12": "Volunteers",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "StudyType": {
        "1": "Case Reports",
        "2": "Clinical Conference",
        "3": "Clinical Study",
        "4": "Comparative Study",
        "5": "Consensus Development Conference",
        "6": "Evaluation Study",
        "7": "Meta-Analysis",
        "8": "Multicenter Study",
        "9": "Scientific Integrity Review",
        "10": "Systematic Review",
        "12": "Validation Study",
        "13": "Observational Study",
        "14": "Biological Specimen Banks",
        "15": "Policy report",
        "16": "Study, design unspecified",
        "17": "Unspecified",
        "18": "Not applicable",
        "19": "Not known"
    },
    "ClinicalTrial": {
        "1": "Adaptive Clinical Trial",
        "2": "Clinical Trial, Phase I",
        "3": "Clinical Trial, Phase II",
        "4": "Clinical Trial, Phase III",
        "5": "Clinical Trial, Phase IV",
        "6": "Controlled Clinical Trial",
        "7": "Randomized Controlled Trial",
        "8": "Clinical Trial Protocol",
        "9": "Clinical Trial, Veterinary",
        "10": "Randomized Controlled Trial, Veterinary",
        "11": "Unspecified",
        "12": "Not applicable",
        "13": "Not known"
    },
    "WHOGHObservatoryFramework": {
        "1": "Cause",
        "2": "Solution",
        "3": "Drug Development",
        "4": "Diagnostics/Screening",
        "5": "Device",
        "6": "Vaccine",
        "7": "Vector Control",
        "8": "Basic Science",
        "9": "Unspecified",
        "10": "Implementation",
        "11": "Evaluation",
        "12": "No research category assigned",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "Disease": {
        "840539006": "COVID-19",
        "43489008": "Crimean-Congo haemorrhagic fever",
        "37109004": "Ebola virus disease",
        "7503002": "Marburg virus disease",
        "19065005": "Lassa fever",
        "651000146102": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV)",
        " 398447004": "Severe Acute Respiratory Syndrome (SARS)",
        "406597005": "Nipah and henipaviral disease",
        "402917003": "Rift Valley Fever",
        "3928002": "Zika",
        "1": "Unspecified",
        "2": "Not applicable",
        "3": "Not known"
    },
    "Pathogen": {
        "1263733001": "SARS-CoV",
        "1263732006": "SARSr-CoV",
        "840533007": "SARS-CoV-2",
        "43489008": "Crimean-Congo haemorrhagic fever virus",
        "243621001": "Genus Nairoviruses",
        "243615000": "Family Bunyaviridae",
        "424206003": "Ebola Virus",
        " 424206003": "Genus Ebolavirus",
        "407325004": "Family Filoviridae",
        "424421007": "Genus Marburgvirus",
        "85944001": "Lassa fever virus",
        "58234003": "Genus Arenavirus",
        "243624009": "Family Arenaviridae",
        "697932005": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV)",
        "868192004": "Subgenus Merbecovirus",
        "84101006": "Human coronavirus",
        "115511007": "Nipah virus",
        "407486001": "Genus Henipavirus",
        "28335002": "Rift Valley Fever virus",
        "82945006": "Genus Phlebovirus",
        "50471002": "Zika virus",
        "28375005": "Flavivirus Genus",
        "243602009": "Family Flaviviridae (including Dengue)",
        "449024000": "Pandemic influenza A (H1N1)",
        "1": "Unspecified",
        "2": "Not applicable",
        "3": "Not known"
    },
    "ResearchCat": {
        "1": "Pathogen: natural history, transmission and diagnostics",
        "2": "Animal and environmental research and research on diseases vectors",
        "3": "Epidemiological studies",
        "4": "Clinical characterisation and management in humans",
        "5": "Infection prevention and control (including health care workers' protection)",
        "6": "Therapeutics research, development and implementation",
        "7": "Vaccines research, development and implementation",
        "8": "Research to inform ethical issues",
        "9": "Public health and Policy",
        "10": "Indirect and Secondary impacts of disease",
        "11": "Health Systems Research",
        "12": "Capacity Strengthening",
        "13": "Disease Surveillance",
        "14": "Other"
    },
    "ResearchSubcat": {
        "1": {
            "1a": "Diagnostics",
            "1b": "Pathogen morphology, shedding & natural history",
            "1c": "Pathogen genomics, mutations and adaptations",
            "1d": "Immunity",
            "1e": "Disease models",
            "1f": "Environmental stability of pathogen"
        },
        "2": {
            "2a": "Animal source and routes of transmission",
            "2b": "Vector biology",
            "2c": "Vector control strategies"
        },
        "3": {
            "3a": "disease transmission dynamics",
            "3b": "disease susceptibility",
            "3c": "impact/effectiveness of control measures",
            "3d": "disease mapping"
        },
        "4": {
            "4a": "Prognostic factors for disease severity",
            "4b": "Disease pathogenesis",
            "4c": "Supportive care, processes of care and management",
            "4d": "Post acute and long term health consequences"
        },
        "5": {
            "5a": "Restriction measures to prevent secondary transmission in communities",
            "5b": "Barriers, PPE, environmental, animal and vector control measures",
            "5c": "IPC in health care settings",
            "5d": "IPC at the human-animal interface"
        },
        "6": {
            "6a": "Pre-clinical studies",
            "6b": "Phase 0 clinical trial",
            "6c": "Phase 1 clinical trial",
            "6d": "Phase 2 clinical trial",
            "6e": "Phase 3 clinical trial",
            "6f": "Phase 4 clinical trial",
            "6g": "Prophylactic use of treatments",
            "6h": "Clinical trial (unspecified trial phase)",
            "6i": "Therapeutics logistics and supply chains and distribution strategies",
            "6j": "Therapeutic trial design",
            "6k": "Adverse events associated with therapeutic administration"
        },
        "7": {
            "7a": "Pre-clinical studies",
            "7b": "Phase 0 clinical trial",
            "7c": "Phase 1 clinical trial",
            "7d": "Phase 2 clinical trial",
            "7e": "Phase 3 clinical trial",
            "7f": "Phase 4 clinical trial",
            "7g": "Clinical trial (unspecified trial phase)",
            "7h": "Vaccine logistics and supply chains and distribution strategies",
            "7i": "Vaccine design and administration",
            "7j": "Vaccine trial design and infrastructure",
            "7k": "Adverse events associated with immunization",
            "7l": "Characterisation of vaccine-induced immunity"
        },
        "8": {
            "8a": "Research to inform ethical issues in Research ",
            "8b": "Research to inform ethical issues related to Public Health Measures",
            "8c": "Research to inform ethical issues in Clinical and Health System Decision-Making",
            "8d": "Research to inform ethical issues in the Allocation of Resources ",
            "8e": "Research to inform ethical issues in Governance ",
            "8f": "Research to inform ethical issues related to Social Determinants of Health, Trust, and Inequities"
        },
        "9": {
            "9a": "Approaches to public health interventions",
            "9b": "Community engagement",
            "9c": "Communication and infodemic management",
            "9d": "Vaccine/Therapeutic/treatment hesitancy",
            "9e": "Policy research and interventions"
        },
        "10": {
            "10a": "Indirect health impacts",
            "10b": "Impacts on social services",
            "10c": "Economic impacts",
            "10d": "Other secondary impacts"
        },
        "11": {
            "11a": "Health service delivery",
            "11b": "Health financing",
            "11c": "Medicines, vaccines & other technologies",
            "11d": "Health information systems",
            "11e": "Health leadership and governance",
            "11f": "Health workforce"
        },
        "12": {
            "12a": "Individual level capacity strengthening",
            "12b": "Institutional level capacity strengthening",
            "12c": "Systemic/environmental components of capacity strengthening",
            "12d": "Cross-cutting"
        },
        "13": {
            "13a": "Disease surveillance detection",
            "13b": "Disease surveillance verification",
            "13c": "Disease surveillance notification",
            "13d": "Disease surveillance response",
            "13e": "Disease surveillance integration",
            "13f": "Analysis for disease surveillance",
            "13g": "Disease surveillance reporting",
            "13h": "Decisions related to disease surveillance",
            "13i": "Disease surveillance evaluation",
            "13j": "Disease surveillance governance"
        }
    }
}
